Joel S Raichlen
Overview
Explore the profile of Joel S Raichlen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
1815
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Puri R, Libby P, Nissen S, Wolski K, Ballantyne C, Barter P, et al.
Eur Heart J Cardiovasc Imaging
. 2014 Jan;
15(4):380-8.
PMID: 24448227
Aims: To evaluate the effect of long-term maximally intensive statin therapy on indices of coronary atheroma composition in a randomized trial, and how these changes relate to modifications of serum...
12.
Puri R, Nissen S, Libby P, Shao M, Ballantyne C, Barter P, et al.
Circulation
. 2013 Sep;
128(22):2395-403.
PMID: 24043299
Background: Baseline C-reactive protein (CRP) levels predict major adverse cardiovascular events (MACE: death, myocardial infarction, stroke, coronary revascularization, and hospitalization for unstable angina). The association between changes in CRP levels...
13.
Puri R, Nissen S, Shao M, Ballantyne C, Barter P, Chapman M, et al.
Eur Heart J
. 2013 Jul;
34(41):3182-90.
PMID: 23886915
Aims: The impact of baseline coronary plaque burden on the clinical outcome in patients receiving aggressive low-density lipoprotein cholesterol (LDL-C) lowering therapy to levels <70 mg/dL is unknown. We assessed...
14.
Puri R, Nissen S, Ballantyne C, Barter P, Chapman M, Erbel R, et al.
Eur Heart J
. 2013 May;
34(24):1818-25.
PMID: 23644179
Aims: Statins can inhibit the progression of coronary atherosclerosis. We aimed to characterize clinical factors that associate with differing measures of coronary atheroma volume following potent statin therapy. Methods And...
15.
Ballantyne C, Pitt B, Loscalzo J, Cain V, Raichlen J
Am J Cardiol
. 2012 Dec;
111(4):506-9.
PMID: 23237107
The low-density lipoprotein (LDL) cholesterol goal of <70 mg/dl, recommended for patients with acute coronary syndrome, typically requires intensive therapy with high-dose statins. The secondary goals of non-high-density lipoprotein (non-HDL)...
16.
Christian J, Finkle J, Ky B, Douglas P, Gutstein D, Hockings P, et al.
Am Heart J
. 2012 Dec;
164(6):846-55.
PMID: 23194484
The ability to make informed benefit-risk assessments for potentially cardiotoxic new compounds is of considerable interest and importance at the public health, drug development, and individual patient levels. Cardiac imaging...
17.
Lind L, Peters S, den Ruijter H, Palmer M, Grobbee D, Crouse 3rd J, et al.
J Am Soc Echocardiogr
. 2012 Aug;
25(10):1120-1127.e1.
PMID: 22884641
Background: The echolucency of the carotid intima-media is related to increased cardiovascular risk factor levels, morbidity, and mortality. The aim of this study was to assess the effect of statins...
18.
Dave J, Halldorsdottir V, Eisenbrey J, Raichlen J, Liu J, McDonald M, et al.
Am J Physiol Heart Circ Physiol
. 2012 May;
303(1):H126-32.
PMID: 22561300
Right heart catheterization is often required to monitor intra-cardiac pressures in a number of disease states. Ultrasound contrast agents can produce pressure modulated subharmonic emissions that may be used to...
19.
Peters S, den Ruijter H, Palmer M, Grobbee D, Crouse 3rd J, OLeary D, et al.
Curr Med Res Opin
. 2012 Apr;
28(6):891-9.
PMID: 22536884
Objective: Carotid intima-media thickness (CIMT) is a marker of atherosclerosis that is commonly used to assess the effect of therapeutic interventions. It is currently unclear to what extent biologically implausible...
20.
Peters S, Bots M, den Ruijter H, Palmer M, Grobbee D, Crouse 3rd J, et al.
J Clin Epidemiol
. 2012 Mar;
65(6):686-95.
PMID: 22459429
Objective: To assess the added value of multiple imputation (MI) of missing repeated outcomes measures in longitudinal data sets analyzed with linear mixed-effects (LME) models. Study Design And Setting: Data...